FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044966465> ?p ?o ?g. }

• W2044966465 endingPage "1103" @default.
• W2044966465 startingPage "1097" @default.
• W2044966465 abstract "Tyrosine kinase inhibitors (TKIs) are now standard treatment for chronic myeloid leukemia (CML). While TKIs have less toxicity than previous treatments, they have side effects that can impact quality of life (QOL). This study compared CML patients taking a TKI for an average of 4.01 years (range 0.50–9.79 years) to age- and gender-matched controls with no history of cancer on measures of symptom burden, depression, fatigue, sleep, and health-related QOL. Compared to controls (n = 62), CML patients (n = 62) taking a TKI (imatinib 55 %, nilotinib 31 %, and dasatinib 14 %) reported significantly worse fatigue severity (p < .001), fatigue interference (p < .001), depression (p = .007), symptom burden (p < .001), and physical QOL (p < .001). TKI patients were also more likely meet established cutoffs for clinically meaningful fatigue (p values < .001) and depression (p = .004). There were no differences in mental QOL or sleep (p values > .010). Regarding specific symptoms, TKI patients were more likely to report nausea, diarrhea, itching, skin changes, swelling of arms or legs, and not looking like themselves (p values < .001). These data suggest the need for interventions to address QOL in CML patients taking TKIs." @default.
• W2044966465 created "2016-06-24" @default.
• W2044966465 creator A5002386870 @default.
• W2044966465 creator A5010075752 @default.
• W2044966465 creator A5033634359 @default.
• W2044966465 creator A5037214066 @default.
• W2044966465 creator A5041443589 @default.
• W2044966465 creator A5045667573 @default.
• W2044966465 creator A5051331100 @default.
• W2044966465 creator A5057933586 @default.
• W2044966465 creator A5059558365 @default.
• W2044966465 creator A5060360947 @default.
• W2044966465 creator A5076396878 @default.
• W2044966465 creator A5082961675 @default.
• W2044966465 date "2012-11-20" @default.
• W2044966465 modified "2023-10-16" @default.
• W2044966465 title "Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison" @default.
• W2044966465 cites W1515774339 @default.
• W2044966465 cites W1527252739 @default.
• W2044966465 cites W1789804267 @default.
• W2044966465 cites W1804627766 @default.
• W2044966465 cites W1977847064 @default.
• W2044966465 cites W2000688031 @default.
• W2044966465 cites W2013450609 @default.
• W2044966465 cites W2028959752 @default.
• W2044966465 cites W2050951274 @default.
• W2044966465 cites W2058948883 @default.
• W2044966465 cites W2087150179 @default.
• W2044966465 cites W2112778345 @default.
• W2044966465 cites W2120222130 @default.
• W2044966465 cites W2129382787 @default.
• W2044966465 cites W2143116594 @default.
• W2044966465 cites W2143939343 @default.
• W2044966465 cites W2151487996 @default.
• W2044966465 cites W2160811827 @default.
• W2044966465 cites W2169942357 @default.
• W2044966465 cites W4250329983 @default.
• W2044966465 doi "https://doi.org/10.1007/s00520-012-1630-5" @default.
• W2044966465 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23179489" @default.
• W2044966465 hasPublicationYear "2012" @default.
• W2044966465 type Work @default.
• W2044966465 sameAs 2044966465 @default.
• W2044966465 citedByCount "93" @default.
• W2044966465 countsByYear W20449664652013 @default.
• W2044966465 countsByYear W20449664652014 @default.
• W2044966465 countsByYear W20449664652015 @default.
• W2044966465 countsByYear W20449664652016 @default.
• W2044966465 countsByYear W20449664652017 @default.
• W2044966465 countsByYear W20449664652018 @default.
• W2044966465 countsByYear W20449664652019 @default.
• W2044966465 countsByYear W20449664652020 @default.
• W2044966465 countsByYear W20449664652021 @default.
• W2044966465 countsByYear W20449664652022 @default.
• W2044966465 countsByYear W20449664652023 @default.
• W2044966465 crossrefType "journal-article" @default.
• W2044966465 hasAuthorship W2044966465A5002386870 @default.
• W2044966465 hasAuthorship W2044966465A5010075752 @default.
• W2044966465 hasAuthorship W2044966465A5033634359 @default.
• W2044966465 hasAuthorship W2044966465A5037214066 @default.
• W2044966465 hasAuthorship W2044966465A5041443589 @default.
• W2044966465 hasAuthorship W2044966465A5045667573 @default.
• W2044966465 hasAuthorship W2044966465A5051331100 @default.
• W2044966465 hasAuthorship W2044966465A5057933586 @default.
• W2044966465 hasAuthorship W2044966465A5059558365 @default.
• W2044966465 hasAuthorship W2044966465A5060360947 @default.
• W2044966465 hasAuthorship W2044966465A5076396878 @default.
• W2044966465 hasAuthorship W2044966465A5082961675 @default.
• W2044966465 hasBestOaLocation W20449664651 @default.
• W2044966465 hasConcept C121608353 @default.
• W2044966465 hasConcept C126322002 @default.
• W2044966465 hasConcept C139719470 @default.
• W2044966465 hasConcept C159110408 @default.
• W2044966465 hasConcept C162324750 @default.
• W2044966465 hasConcept C2776867660 @default.
• W2044966465 hasConcept C2777413986 @default.
• W2044966465 hasConcept C2777583451 @default.
• W2044966465 hasConcept C2778729363 @default.
• W2044966465 hasConcept C2778820342 @default.
• W2044966465 hasConcept C2779536868 @default.
• W2044966465 hasConcept C2779951463 @default.
• W2044966465 hasConcept C2780580376 @default.
• W2044966465 hasConcept C71924100 @default.
• W2044966465 hasConceptScore W2044966465C121608353 @default.
• W2044966465 hasConceptScore W2044966465C126322002 @default.
• W2044966465 hasConceptScore W2044966465C139719470 @default.
• W2044966465 hasConceptScore W2044966465C159110408 @default.
• W2044966465 hasConceptScore W2044966465C162324750 @default.
• W2044966465 hasConceptScore W2044966465C2776867660 @default.
• W2044966465 hasConceptScore W2044966465C2777413986 @default.
• W2044966465 hasConceptScore W2044966465C2777583451 @default.
• W2044966465 hasConceptScore W2044966465C2778729363 @default.
• W2044966465 hasConceptScore W2044966465C2778820342 @default.
• W2044966465 hasConceptScore W2044966465C2779536868 @default.
• W2044966465 hasConceptScore W2044966465C2779951463 @default.
• W2044966465 hasConceptScore W2044966465C2780580376 @default.
• W2044966465 hasConceptScore W2044966465C71924100 @default.
• W2044966465 hasIssue "4" @default.
• W2044966465 hasLocation W20449664651 @default.

• next